Search research articles
Contact Us
Filters
Showing results (111-120 of 265) with videos related to
Page
of 27
Sort By:
Cancer Treatment Reviews
|
May 22, 2024
Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer
Luca Licata, Maria Vittoria Dieci, Carmine De Angelis, et al.
The Oncologist
|
November 8, 2025
Digital integration of narrative medicine and patient-reported outcome measures to improve understanding of quality of life in metastatic breast cancer: the PERGIQUAL study
Alessandra Fabi, Maria Cecilia Cercato, Alessandro Rossi, et al.
Breast (Edinburgh, Scotland)
|
January 14, 2021
Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO)
Lorenza Marino, Valentina Lancellotta, Pierfrancesco Franco, et al.
Future Oncology (London, England)
|
February 13, 2015
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice
Alessandra Fabi, Luca Moscetti, Mariangela Ciccarese, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 25, 2010
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
Luigi Celio, Sergio Frustaci, Angela Denaro, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 15, 2017
Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification
Cristiana Ercolani, Caterina Marchiò, Anna Di Benedetto, et al.
American Journal of Clinical Oncology
|
May 19, 2025
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Federica Martorana, Maria V Sanò, Alessandra Fabi, et al.
BMC Cancer
|
April 2, 2009
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
Alessandra Fabi, Giulio Metro, Michelangelo Russillo, et al.
Endocrine
|
November 18, 2023
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer
Viviana M Bimonte, Giuseppina Catanzaro, Agnese Po, et al.
Journal of Neurology
|
February 20, 2021
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)
Veronica Villani, Elena Anghileri, Luca Prosperini, et al.
Page
of 27
Search research articles
Search
Showing results (111-120 of 265) with videos related to
Sort By:
Page
of 27
Cancer Treatment Reviews
|
May 22, 2024
Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer
Luca Licata, Maria Vittoria Dieci, Carmine De Angelis, et al.
The Oncologist
|
November 8, 2025
Digital integration of narrative medicine and patient-reported outcome measures to improve understanding of quality of life in metastatic breast cancer: the PERGIQUAL study
Alessandra Fabi, Maria Cecilia Cercato, Alessandro Rossi, et al.
Breast (Edinburgh, Scotland)
|
January 14, 2021
Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO)
Lorenza Marino, Valentina Lancellotta, Pierfrancesco Franco, et al.
Future Oncology (London, England)
|
February 13, 2015
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice
Alessandra Fabi, Luca Moscetti, Mariangela Ciccarese, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 25, 2010
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
Luigi Celio, Sergio Frustaci, Angela Denaro, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 15, 2017
Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification
Cristiana Ercolani, Caterina Marchiò, Anna Di Benedetto, et al.
American Journal of Clinical Oncology
|
May 19, 2025
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Federica Martorana, Maria V Sanò, Alessandra Fabi, et al.
BMC Cancer
|
April 2, 2009
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
Alessandra Fabi, Giulio Metro, Michelangelo Russillo, et al.
Endocrine
|
November 18, 2023
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer
Viviana M Bimonte, Giuseppina Catanzaro, Agnese Po, et al.
Journal of Neurology
|
February 20, 2021
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)
Veronica Villani, Elena Anghileri, Luca Prosperini, et al.
Page
of 27